Skip to the main content.
Contact Us
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus

Picture of Kirk Jensen Kirk Jensen Dec 15, 2016 1:17:05 PM

Microbiology Host-Pathogen Interactions Biofilm Cellular Analysis

ACCESS TO ARTICLE →